CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk Chemicals Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd

BSE 543321 TATVA INE0GK401011
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Filing rhythm · 60 trading days

25 filings · 6 material · busiest 2026-07-17

What it files

Filings

25 in the window

  1. 19 August 2026

    Change in Management

    Change in Management

    Resignation of a Senior Management Personnel of the Company.

    Company Update / Change in Management View filing →

  2. 18 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement - Disclosure under Regulation 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ....

    Company Update / Newspaper Publication View filing →

  3. 11 August 2026

    General

    Communication To Shareholders - Final Dividend For FY 2025-26 - Intimation On Tax Deduction At Source (TDS) / Withholding Tax On Dividend

    Communication to Shareholders - Final Dividend for FY 2025-26 - Intimation on Tax Deduction at source (TDS) / withholding tax on Dividend

    Company Update / General View filing →

  4. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  5. 7 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  6. 3 August 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  7. 31 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  8. 24 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  9. 24 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  10. 24 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  11. 22 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  12. 21 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →

  13. 21 July 2026

    Concall Transcript

    Earnings Call Transcript

    Transcript of the earnings call held on 17 July 2026 post announcement of the financial results of the Company for the quarter ended 30 June 2026.

    Company Update / Earnings Call Transcript View filing →

  14. 20 July 2026

    General

    Announcement Under Regulation 30-Company Update

    Groundbreaking Ceremony (Bhoomi Pujan) at the new greenfield unit at Dahej - III, Dahej Industrial Estate, Taluka: Vagra, District: Bharuch, Gujarat, India.

    Company Update / General View filing →

  15. 17 July 2026

    Results

    Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30 June 2026

    Enclosed

    Result / Financial Results View filing →

  16. 17 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting Held On 17.07.2026

    Outcome Of The Board Meeting Held On 17.07.2026.

    Board Meeting / Outcome of Board Meeting View filing →

  17. 17 July 2026

    Change in Directorate

    Change in Directorate

    Detailed disclosure is enclosed.

    Company Update / Change in Directorate View filing →

  18. 17 July 2026

    General

    Announcement Under Regulation 30-Capacity Addition

    Enclosed herewith intimation regarding Capacity Addition.

    Company Update / General View filing →

  19. 17 July 2026

    Investor Presentation

    Investor Presentation

    Investor Presentation for the quarter ended 30 June 2026.

    Company Update / Investor Presentation View filing →

  20. 17 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Link of Audio Recording of the Earnings call held on Friday, 17July 2026 at 05:00 p.m. (IST) is attached.

    Company Update / Analyst / Investor Meet View filing →

  21. 10 July 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 17.07.2026

    Tatva Chintan Pharma Chem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2026 ,inter alia, to consider and approve and take on record ....

    Board Meeting / Board Meeting View filing →

  22. 10 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of ....

    Company Update / Analyst / Investor Meet View filing →

  23. 6 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  24. 23 June 2026

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  25. 12 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Analyst / Investor Meet View filing →